Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.82 USD | +2.41% | +16.82% | -23.14% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 275K | Capitalization | 140M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -63M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 510 x |
P/E ratio 2024 * |
-2.57
x | P/E ratio 2025 * |
-2.37
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.99% |
Latest transcript on PDS Biotechnology Corporation
1 day | +2.41% | ||
1 week | +16.82% | ||
Current month | +14.03% | ||
1 month | +16.11% | ||
3 months | -29.39% | ||
6 months | -16.04% | ||
Current year | -23.14% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Bedu-Addo
FOU | Founder | 59 | 19-03-14 |
Director of Finance/CFO | 55 | Dec. 03 | |
David Schaaf
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Glover
CHM | Chairman | 60 | 19-04-01 |
Otis Brawley
BRD | Director/Board Member | 64 | 20-11-02 |
Richard Sykes
BRD | Director/Board Member | 79 | 19-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 3.82 | +2.41% | 430,970 |
24-05-02 | 3.73 | +3.32% | 375,315 |
24-05-01 | 3.61 | +7.76% | 675,778 |
24-04-30 | 3.35 | -1.18% | 258,935 |
24-04-29 | 3.39 | +3.67% | 436,535 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.14% | 140M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- PDSB Stock